Table 4.
Multivariate analysis of the clinical factors predictive of complete symptom resolution within one week based on dexlansoprazole and esomeprazole administration
| Time | PPI | Clinical factors | CSR | Coefficient of variation | Odds ratio (95%CI) | P value |
| Day 1 | Dexlansoprazole | Null | ||||
| Esomeprazole | Female | 15.80% | -1.249 ± 0.543 | 0.285 (0.103-0.789) | 0.022 | |
| Day 3 | Dexlansoprazole | Null | ||||
| Esomeprazole | Female | 18.40% | -1.254 ± 0.519 | 0.287 (0.099-0.832) | 0.016 | |
| Day 7 | Dexlansoprazole | Null | ||||
| Esomeprazole | Null |
CSR: Complete symptom resolution; PPI: Proton pump inhibitor.